ConductScience.org, home

Paper393427

m-AMSA and PALA: two new agents in cancer chemotherapy.

Rozencweig M and 3 others. Cancer Chemother Pharmacol, 1979. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. m-AMSA and PALA: two new agents in cancer chemotherapy. Papers, record 393427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
m-AMSA and PALA: two new agents in cancer chemotherapy.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rozencweig MM
2Von Hoff DDD D
3Cysyk RLR L
4Muggia FMF M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoacridinesMajor topic
Antineoplastic AgentsMajor topic
Aspartic AcidMajor topic
Organophosphorus CompoundsMajor topic
Phosphonoacetic AcidMajor topic
Animals
Cell Division
Kinetics
Neoplasms, Experimental

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1204947Oral absorption and selective tissue localization of 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Pharmacology1978https://conductscience.org/library/papers/204947PubMed
24463003The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.Eur J Cancer (1965)1974https://conductscience.org/library/papers/4463003PubMed
3476706Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA).Cancer Treat Rep1979https://conductscience.org/library/papers/476706PubMed
4328129VM 26 and VP 16-213: a comparative analysis.Cancer1977https://conductscience.org/library/papers/328129PubMed
576512Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.Cancer Res1978https://conductscience.org/library/papers/76512PubMed
615938285Comparative activities of aspartate transcarbamylase in various tissues of the rat.Proc Soc Exp Biol Med1967https://conductscience.org/library/papers/15938285PubMed
721782The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.Drug Metab Dispos1977https://conductscience.org/library/papers/21782PubMed
84348752The use of drugs in combination for the treatment of cancer: rationale and results.N Engl J Med1973https://conductscience.org/library/papers/4348752PubMed
9280145Antiviral activities of 4'-(9-acridinylamino)-methanesulfon-M-aniside (SN11841).Ann N Y Acad Sci1977https://conductscience.org/library/papers/280145PubMed
10750106The clinical evaluation of analogues. I. The overall problem.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/750106PubMed
111034560DNA-binding characteristics of acridinylmethanesulphonanilide drugs: comparison with antitumour properties.Eur J Cancer (1965)1976https://conductscience.org/library/papers/1034560PubMed
127055806Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.Cancer Res1982https://conductscience.org/library/papers/7055806PubMed
13890691Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.Cancer Treat Rep1977https://conductscience.org/library/papers/890691PubMed
14361225An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.Cancer Treat Rep1978https://conductscience.org/library/papers/361225PubMed
15831730Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo.Biochem Pharmacol1977https://conductscience.org/library/papers/831730PubMed
1612870Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis.Cell1976https://conductscience.org/library/papers/12870PubMed
17279397Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.Cancer Res1978https://conductscience.org/library/papers/279397PubMed
184609763An assessment of the immunosuppressive activity of the anti-tumour compound--4'-((9-acridinyl)amino)methanesulphon-m-anisidide (m-AMSA).Eur J Cancer (1965)1974https://conductscience.org/library/papers/4609763PubMed
19144557Chemotherapy of human colon cancer xenografts in athymic nude mice.Cancer1977https://conductscience.org/library/papers/144557PubMed
20361222Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.Cancer Treat Rep1978https://conductscience.org/library/papers/361222PubMed

See all 35 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
27893848The Open Form Inducer Approach for Structure-Based Drug Design.PLoS One2016https://conductscience.org/library/papers/27893848PubMed
6896455Clonal variation in the sensitivity of B16 melanoma to m-AMSA.Br J Cancer1982https://conductscience.org/library/papers/6896455PubMed
6893934Enhanced killing of mammalian cells by radiation combined with m-AMSA.Br J Cancer1980https://conductscience.org/library/papers/6893934PubMed
6688382Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6688382PubMed
6549551Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules.Clin Exp Metastasis1984https://conductscience.org/library/papers/6549551PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/393427

GET https://conductscience.org/api/papers/v1/393427/references?page=2